Author： Tubaro A.
Publisher： Adis International
ISSN： 1170-229X
Source： Drugs & Aging, Vol.20, Iss.3, 2003-01, pp. : 185-195
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
A Risk-Benefit Assessment of Treatment with Finasteride in Benign Prostatic Hyperplasia
By Ekman P.
Drug Safety, Vol. 18, Iss. 3, 1998-03 ,pp. :
Access to resources
Recommend
Treatment options for benign prostatic hyperplasia
By Thurlow R.J.
Expert Opinion on Emerging Drugs, Vol. 3, Iss. 1, 1998-06 ,pp. :
Dutasteride for the treatment of benign prostatic hyperplasia
Expert Opinion on Pharmacotherapy, Vol. 14, Iss. 10, 2013-07 ,pp. :
NX 1207 is promising for the treatment of benign prostatic hyperplasia
Inpharma, Vol. 1, Iss. 1617, 2007-01 ,pp. :